23 March 2020 – Takis on “Il Corriere”: from cancer immunotherapy to Covid-19 vaccine
Takis is an Italian company, founded by a small group of researchers who never thought of leaving Italy, despite the difficulty in doing good scientific research in this country .
This is a story of sacrifices, but also of success. After years of research in the field of anticancer immunotherapy, our experience has led us to take the field against Covid-19. We can and must help fight this pandemics.
We are proud not to have given up and to represent the excellence of Italian research in Europe and worldwide.
Read the article: https://bit.ly/3dNPOFV